Pintera J, Krácmar C
Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(6):894-901.
In the population of 55 high-titered anti-HBs donors only 23 tolerated plasmapheretic collections without intermittent elevations or ALT activity. In 4 persons a RIA-detected HBsAg circulated along with high-titered anti-HBs. In 73.8% of donors anti-HBs was accompanied by an anti-HBe antibody which also appeared in the HBIG preparation HEPAGA and can perhaps participate on its protective influence. Circulating immune complexes (CIC) were detected in 89.1%. No HBsAg, HBeAg, or albumin were detected in CIC isolated from anti-HBs sera in spite of their content in CIC isolated from HBsAg carriers. Thus, CIC carriers found in normal population with a prevalence of 1.0% can be divided into 0.6% of HHsAg-containing CIC and 0.4% of HBsAg-lacking CIC carriers with anti-HBs attesting the hepatitic origin in a considerable part of them. The continuing production of alienated CIC-forming antigens and a common origin combine these two forms of post-hepatitic development to a syndrome of post-hepatitic immunopathy which seems to be the most frequent source of CIC in a normal population. All the donors and HEPAGA were anti-HBc positive, as well, but this antibody possessed the IgM character only in 4.3% of the donors. Mean serum ferritin levels in the anti-HBs donors were distinctly higher than those found in normal populations of both men and women but the differences were statistically not significant due to high variability.
在55名抗-HBs高滴度献血者群体中,只有23人能够耐受血浆置换采集,谷丙转氨酶(ALT)活性没有间歇性升高。4人经放射免疫分析(RIA)检测发现乙肝表面抗原(HBsAg)与抗-HBs高滴度同时存在。73.8%的献血者抗-HBs伴有抗-HBe抗体,该抗体也出现在乙肝免疫球蛋白制剂HEPAGA中,可能参与其保护作用。89.1%的献血者检测到循环免疫复合物(CIC)。尽管从HBsAg携带者分离的CIC中含有乙肝表面抗原(HBsAg)、乙肝e抗原(HBeAg)或白蛋白,但从抗-HBs血清分离的CIC中未检测到这些物质。因此,在正常人群中发现的CIC携带者患病率为1.0%,可分为含HBsAg的CIC携带者0.6%和不含HBsAg的CIC携带者0.4%,其中相当一部分抗-HBs携带者证明有肝炎病史。异化的CIC形成抗原的持续产生和共同起源将这两种肝炎后发展形式合并为一种肝炎后免疫病综合征,这似乎是正常人群中CIC最常见的来源。所有献血者和HEPAGA也都是抗-HBc阳性,但该抗体仅在4.3%的献血者中具有IgM特性。抗-HBs献血者的平均血清铁蛋白水平明显高于正常男性和女性人群,但由于变异性高,差异无统计学意义。